Clinical Trial Update: Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is enrolling to evaluate formulated methylene blue for treating squamous cell carcinoma of the skin in patients who are inoperable and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma
• Squamous Cell Carcinoma of the Skin

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Daryoush Hamidi Alamdari, PhD | Conditions: SCC - Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma of Skin | Phase 3 | Status: ENROLLING_BY_INVITATION